Insider Trading History of Krop Julie

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Krop Julie since 2016. This trader's CIK number is 1643127. At the time of last reporting, Krop Julie was the Officer of Aquestive Therapeutics, Inc.. (stock ticker symbol AQST). Also see all insider trading activities at Aquestive Therapeutics, Inc..

Note that in the past Krop Julie also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Amag Pharmaceuticals, Inc. (AMAG) by Krop Julie

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2019 AMAG 10,000 $99,100 0 $0 0 $0
2017 AMAG 0 $0 6,829 $144,994 0 $0
2016 AMAG 0 $0 4,938 $122,462 0 $0

Yearly summary of insider trading at Aquestive Therapeutics, Inc. (AQST) by Krop Julie

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2026 AQST 0 $0 25,000 $125,400 25,000 $17,825


Insider trading activities at 2 companies by Krop Julie:

1. Amag Pharmaceuticals, Inc. (AMAG)

2. Aquestive Therapeutics, Inc. (AQST)

Table 1. Insider trading of Amag Pharmaceuticals, Inc. (AMAG) by Krop Julie

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2019-05-28 AMAG Buy 10,000 9.91 99,100
2017-07-13 AMAG Sale 4,938 20.00 98,760
2017-05-01 AMAG Sale 1,891 24.45 46,234
2016-10-20 AMAG Sale 4,938 24.80 122,462

Table 2. Insider trading of Aquestive Therapeutics, Inc. (AQST) by Krop Julie

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2026-06-23 AQST Sale 25,000 5.02 125,400
2026-06-23 AQST Option Ex 25,000 .71 17,825

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Krop Julie (Officer of Aquestive Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.